Similar articles

• Matching or selection bias in the fenoterol studies?

  Lanes SF. Lanes SF. N Z Med J. 1992 Oct 14;105(943):413-4. N Z Med J. 1992. PMID: 1461599 No abstract available.
• Fenoterol: enough is enough.

  Garrett JE, Lanes S, Kolbe J, Rea HH. Garrett JE, et al. N Z Med J. 1992 Oct 14;105(943):414. N Z Med J. 1992. PMID: 1461600 No abstract available.
• The use of beta agonists and the risk of death and near death from asthma.

  Pearce N. Pearce N. J Clin Epidemiol. 2009 Jun;62(6):582-7. doi: 10.1016/j.jclinepi.2009.01.004. J Clin Epidemiol. 2009. PMID: 19422997 No abstract available.
• Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.

  Beasley R, Pearce N, Crane J, Burgess C. Beasley R, et al. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):325-7. doi: 10.1159/000237016. Int Arch Allergy Immunol. 1995. PMID: 7613161 Review.
• A review of the studies of the asthma mortality epidemic in New Zealand.

  Beasley R, Burgess C, Crane J, Pearce N. Beasley R, et al. Allergy Proc. 1995 Jan-Feb;16(1):27-32. doi: 10.2500/108854195778690075. Allergy Proc. 1995. PMID: 7768457 Review. No abstract available.